Cargando…
Adenoviral Pneumonia During Etanercept Treatment in a Patient with Rheumatoid Arthritis
Inhibitors of tumor necrosis factor-alpha (TNF-α) have been approved for treating rheumatoid arthritis. As one of the biological response modifiers, etanercept has also been used in the treatment of psoriatic arthritis and inflammatory bowel disease. While etanercept is effective, certain infectious...
Autores principales: | Kang, Min-Jung, Kim, Myung-Sin, Choi, Eun-Hwa, Lee, Kyoung-Eun, Kim, You-Kyoung, Choi, Hee-Jung |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Korean Association of Internal Medicine
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2687603/ https://www.ncbi.nlm.nih.gov/pubmed/17427651 http://dx.doi.org/10.3904/kjim.2007.22.1.63 |
Ejemplares similares
-
Etanercept-Induced Systemic Lupus Erythematosus in a Patient with Rheumatoid Arthritis
por: Kang, Min-Jung, et al.
Publicado: (2006) -
Etanercept in the treatment of rheumatoid arthritis
por: Haraoui, Boulos, et al.
Publicado: (2007) -
Etanercept for Treating Rheumatoid Arthritis
por: Moreland, Larry W
Publicado: (2000) -
Safety of etanercept in elderly subjects with rheumatoid arthritis
por: Lurati, Alfredomaria, et al.
Publicado: (2010) -
Optimal dose of etanercept in the treatment of rheumatoid arthritis
por: Curtis, Elizabeth Mary, et al.
Publicado: (2014)